Duke Cancer Center Southpoint — Durham, North Carolina

Duke Cancer Center Southpoint is a clinical research site located in Durham, North Carolina, United States 27713.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Cancer Center Southpoint has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center Southpoint?

Duke Cancer Center Southpoint has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center Southpoint conducted?

Duke Cancer Center Southpoint has 2 clinical trials on record, with 2 currently active. Their work covers Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma.

Is Duke Cancer Center Southpoint accredited by Crixeo Health?

Duke Cancer Center Southpoint has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Center Southpoint?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.